Information  X 
Enter a valid email address

Feedback PLC (FDBK)

  Print          Annual reports

Thursday 23 September, 2021

Feedback PLC

Official Launch of Bleepa Box

RNS Number : 6635M
Feedback PLC
23 September 2021
 

Feedback plc

 

RNS REACH

 

Feedback announces official launch of Bleepa Box to enable connected imaging in remote locations

 

· Enables capture and rapid transfer of medical images from remote locations to the Bleepa platform over mobile networks

· Images acquired in remote settings can be instantly reviewed by specialists in other locations, connected via the Bleepa platform for instant case discussion, enabling point of care patient management

· Multiple commercial opportunities including veterinary, international markets and the military

 

 

London, 23 September 2021 : Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist clinical communication company, announces that following the success of the store and forward concept delivered in partnership with the equine division of CVS Group plc it is officially launching Bleepa Box, a specialist tool to enable image transfer from remote settings to the Bleepa platform.

 

Bleepa Box is a small tablet device that connects to imaging machines in order to securely push images to Bleepa over a mobile network from remote locations. Crucially Bleepa does not need WiFi access. Images are downloaded from the imaging machine onto the Bleepa Box then automatically pushed to Bleepa. The clinician who acquired the images can then review the images directly on the Bleepa Box and can make onward referrals or start a conversation with a specialist for input on the case whilst still in the remote location. This enables rapid decision making and treatment of the patient within that first visit, at the point of care, for cases that previously would have required transfer to treatment centres for imaging and management. This enables new capabilities around remote investigation and patient management, allowing patient imaging to be carried out and discussed in settings that were previously unreachable for traditional care models.  

 

In addition to the veterinary imaging market which is growing at a compound annual growth rate of 6.7% and is expected to be worth an estimated £2.24bn in the UK1 by 2025, Bleepa Box's remote image capabilities are relevant to a number of other significant commercial opportunities including the delivery of rural imaging for TB screening services in India, as announced in our MOU with Qure.ai on 14 September 2021 and routes to support the military infield market.

 

Dr Tom Oakley, CEO of Feedback, said: "This technology was a solution created, designed and launched to support the work we are doing in the veterinary market with CVS and we are now taking the steps to formally build a brand around this capability.  Imaging of horses is typically done in remote stables without WiFi, but there is often the need for timely advice and guidance by specialists whilst the vet is with the animal. We developed the store and forward technology that enables them to analyse and treat animals on site, which reduces the vet's workload, travel time and is certainly better for the animal.  However, clearly there are other markets that have this requirement and formally branding the solution as Bleepa Box enables us to build a market around this capability across a range of industries. We anticipate that the product can be sold in combination with Bleepa or potentially as a standalone offering to facilitate image sharing to other third-party systems such as PACS."

 

Further information on Bleepa Box and the company's product focus can be found on the Company's website https://fbkmed.com/feedback-plc/reports-and-presentations/

 

1.  Veterinary Imaging Market - Global Forecast to 2025 | MarketsandMarkets

 

-Ends-

 



 

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

[email protected]



Panmure Gordon (UK) Limited (NOMAD and Broker)

Emma Earl/Freddy Crossley (Corporate Finance)

Rupert Dearden (Corporate Broking)

+44 (0)20 7886 2500



Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus/Nick Rome/Nicholas Johnson

07980 541 893 or 07748 325 236 or 07884 664 686

 

Notes to Editors

 

Feedback plc (AIM: FDBK) is a pioneer of regulated clinical communication products. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go. 

 

Its highly scalable Software as a Service ("SaaS") based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care providers. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of clinical review.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUUOVRAUUKUAR

a d v e r t i s e m e n t